From: The molecular portraits of breast tumors are conserved across microarray platforms
A. | Relapse-Free survival | |
---|---|---|
Variable | Hazard Ratio (95% CI) | p-value |
Age, per decade | 1.04 (0.90–1.20) | 0.64 |
ER status | 0.59 (0.41–0.83) | 0.003 |
Node status | 1.41 (0.98–2.04) | 0.07 |
Tumor grade 2 vs. 1 | 2.41 (1.08–5.36) | 0.032 |
Tumor grade 3 vs. 1 | 3.98 (1.80–8.82) | 0.0007 |
Size | 1.60 (1.31–1.95) | <0.0001 |
B. | Relapse-Free survival | |
Variable | Hazard Ratio (95% CI) | p-value |
Age, per decade | 1.08 (0.94–1.24) | 0.29 |
ER status | 0.69 (0.42–1.13) | 0.14 |
Node status | 1.35 (0.92–1.98) | 0.13 |
Tumor grade 2 vs. 1 | 1.88 (0.82–4.32) | 0.14 |
Tumor grade 3 vs. 1 | 2.58 (1.08–6.12) | 0.03 |
Size | 1.59 (1.30–1.95) | <0.0001 |
Basal-like vs. LumA | 2.02 (1.05–3.90) | 0.036 |
HER2+/ER- vs. LumA | 3.47 (1.78–6.76) | 0.0003 |
LumB vs. LumA | 1.92 (1.07–3.45) | 0.028 |
IFN vs. LumA | 1.40 (0.67–2.91) | 0.37 |
Normal-like vs. LumA | 1.56 (0.59–4.16) | 0.37 |